Chinese english Germany Korea

ANTI-DENN (CT)

化学構造式
CAS番号.
化学名:
别名:
英語名:
ANTI-DENN (CT)
英語别名:
ANTI-DENN;Anti-Rab3gep;Anti-Kiaa0358;ANTI-MADD (CT);ANTI-DENN (CT);ANTI-MADD (C-TERMINUS);ANTI-RAT MADD/DENN (CT);ANTI-HUMAN MADD/DENN (CT);ANTI-MOUSE MADD/DENN (CT);ANTI-MADD, CARBOXY TERMINUS
CBNumber:
CB0215187
化学式:
分子量:
0
MOL File:
Mol file

ANTI-DENN (CT) 物理性質

貯蔵温度 :
−20°C

安全性情報

ANTI-DENN (CT) 価格

メーカー 製品番号 製品説明 CAS番号 包装 価格 更新時間 購入

ANTI-DENN (CT) 化学特性,用途語,生産方法

ANTI-DENN (CT) 上流と下流の製品情報

原材料

準備製品

ANTI-DENN (CT) 生産企業

Global( 8)Suppliers
名前 電話番号 電子メール 国籍 製品カタログ 優位度
Riedel-de Haen AG --
 United States 6825 87
SIGMA-RBI --
 Switzerland 6913 91
Cell Sciences, Inc. --
 United States 1065 76
Chemicon Internatinal, Inc. --
 custserv@chemicon.com United States 4175 65
Kamiya Biomedical Company --
 ordering@kamiyabiomedical.com United States 736 72
EMD Biosciences, Inc. --
 technical@calbiochem.com United States 6529 66
VWR International --
 solutions@vwr.com United Kingdom 6554 82
BIOTREND Chemikalien GmbH --
 jaeger@biotrend.com Germany 6115 76
  • ANTI-HUMAN MADD/DENN (CT)
  • ANTI-HUMAN MADD/DENN (CT) POLYCLONAL ANTIBODY
  • ANTI-DENN
  • ANTI-DENN (CT)
  • ANTI-DENN, C-TERMINAL (1570-1588), HUMAN
  • ANTI-DENN, C-TERMINAL (1570-1588) RABBIT PAB
  • ANTI-RAT MADD/DENN (CT)
  • ANTI-RAT MADD/DENN (CT) POLYCLONAL ANTIBODY
  • ANTI-MADD/DENN, ACTIVATOR OF MAPK PATHWAY, HUMAN, AA 1570-1588, C-TERM
  • ANTI-MADD, CARBOXY TERMINUS
  • ANTI-MADD (CT)
  • ANTI-MADD, C-TERMINAL (1570-1588), HUMAN
  • ANTI-MADD, C-TERMINAL (1570-1588), HUMAN (RABBIT)
  • ANTI-MADD, C-TERMINAL (1570-1588) RABBIT PAB
  • ANTI-MADD (C-TERMINUS)
  • ANTI-MAP-KINASE ACTIVATING DEATH DOMAIN (CT)
  • ANTI-MOUSE MADD/DENN (CT)
  • ANTI-MOUSE MADD/DENN (CT) POLYCLONAL ANTIBODY
  • Anti-MADD antibody produced in rabbit
  • Differentially expressed in normal and neoplastic cells
  • Insulinoma glucagonoma clone 20
  • Rab3 GDP/GTP exchange factor
  • Anti-Kiaa0358
  • Anti-Map-kinase activating death domain
  • Anti-Rab3gep
Copyright 2017 © ChemicalBook. All rights reserved